Asensus Surgical, Inc.
ASXC
ASXC was delisted on the 21st of August, 2024.
151 hedge funds and large institutions have $418M invested in Asensus Surgical, Inc. in 2018 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 59 increasing their positions, 31 reducing their positions, and 19 closing their positions.
105% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 19
90% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 31
53% more capital invested
Capital invested by funds: $273M → $418M (+$146M)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
14% more funds holding
Funds holding: 132 → 151 (+19)
24% less call options, than puts
Call options by funds: $18.2M | Put options by funds: $23.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$27.1M |
| 2 |
BlackRock
New York
|
+$14.1M |
| 3 |
State Street
Boston,
Massachusetts
|
+$8.19M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$7.08M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Aisling Capital
New York
|
-$20.8M |
| 2 |
SHI
SV Health Investors
Boston,
Massachusetts
|
-$4.76M |
| 3 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
-$3.82M |
| 4 |
Goldman Sachs
New York
|
-$2.11M |
| 5 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$1.63M |
ASXC Hedge Fund Activity: Q3 2018 in Review
151 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Asensus Surgical, Inc. (ASXC) for Q3 2018, worth a combined $418M — up 53% from $273M a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new ASXC positions and 19 closed out — a net gain of 20 holders — while 59 added to existing stakes and 31 trimmed.
The largest buyer was Mirae Asset Global Investments, opening a new position worth an estimated $27.1M. The largest seller was Aisling Capital, cutting an estimated $20.8M.
- 151 institutional investors held Asensus Surgical, Inc. (ASXC) as of Q3 2018, up from 132 in Q2 2018.
- Funds reported $418M of Asensus Surgical, Inc. stock for Q3 2018, up 53% quarter-over-quarter.
- 39 funds opened new Asensus Surgical, Inc. positions in Q3 2018 and 19 closed out, a net change of +20 holders.
- The largest Asensus Surgical, Inc. buyer in Q3 2018 was Mirae Asset Global Investments, an estimated $27.1M added.
- The largest Asensus Surgical, Inc. seller in Q3 2018 was Aisling Capital, an estimated $20.8M sold.
Based on aggregated 13F filings for Q3 2018.